Skip to main content


Figure 2 | Arthritis Research & Therapy

Figure 2

From: Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model

Figure 2

Kinetic gait analysis. Peak vertical force (mean (standard deviation)) recorded before (baseline) and four and eight weeks after anterior cruciate ligament transection in dogs. Line plots representation includes respective values for A) placebo-control and B) tiludronate treated dogs. There was a significant time effect (P < 0.01), a group effect (P = 0.05) and a time per group interaction (P < 0.01) with PVF value reaching 35% higher in tiludronate than in placebo-control at Week 8 (P = 0.04).

Back to article page